Indo Borax FY26: Revenue up, profits up, and a new ownership chapter
Frequently Asked Questions
FY26 consolidated revenue was Rs 215.45 crore, EBITDA was Rs 44.16 crore and PAT was Rs 50.27 crore, as stated in the investor presentation.
Q4 FY26 consolidated operating revenue was Rs 63.01 crore, EBITDA was Rs 12.82 crore and PAT was Rs 14.53 crore, as shown in the quarterly highlights.
The presentation states boric acid capacity of 20,000 MTPA and DOT capacity of 6,000 MTPA at the Pithampur, MP facility.
The board recommended a final dividend of Rs 10 per share and a special dividend of Rs 30 per share for FY26, subject to shareholder approval at the AGM.
Yes. The auditor highlighted an inter-corporate deposit/loan of Rs 5.09 crore to a party under corporate insolvency resolution process; recovery outcome is pending at NCLT and interest was not provided in FY26 due to uncertainty.
The presentation notes a Share Purchase Agreement executed in January 2026 involving about 50.80% of equity (change in controlling stake) with buyers including Zenrock Chemicals Pvt Ltd and certain investment funds, with transfer date stated as January 23, 2026.
The presentation states steel and refractory applications contribute about 55%–60% of boric acid demand, with other uses including ceramics/tiles, plywood, pharma, personal and home care, and insecticides/pesticides.
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
